Paul Gitman, Director at BIOSPECIFICS TECHNOLOGIES CORP (BSTC), sold 10,000 shares at $25.00 ($250K) on 2014-01-22, disclosed to the SEC on 2014-01-23.
Scheduled sale ($250k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $25.00 | 2,196 | $55K | 22.0% |
| 2 | $25.00 | 7,804 | $195K | 78.0% |
| Total | $25.00 avg | 10,000 | $250K | 100% |
| Filing → |
| BSTC | SELL | 2018-08-29 | $945K | — | Filing → |
| BSTC | SELL | 2018-08-29 | $883K | — | Filing → |
| BSTC | SELL | 2015-07-21 | $461K | — | Filing → |